B. Rawson, N. S. (2020). Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand. Journal of Population Therapeutics and Clinical Pharmacology, 27(2), e58-e67. https://doi.org/10.15586/jptcp.v27i2.673